Consolidated Balance Sheet

Kringle Pharma,Inc. - Filing #7264672

Concept As at
2025-03-31
As at
2024-09-30
Consolidated balance sheet
Balance sheet
Assets
Non-current assets
Property, plant and equipment
Property, plant and equipment
JPY
JPY
Investments and other assets
Investments and other assets
24,982,000 JPY
1,122,000 JPY
Non-current assets
24,982,000 JPY
1,122,000 JPY
Current assets
Cash and deposits
1,886,137,000 JPY
2,313,475,000 JPY
Raw materials and supplies
250,405,000 JPY
294,514,000 JPY
Advance payments to suppliers
80,424,000 JPY
66,757,000 JPY
Other
14,184,000 JPY
23,993,000 JPY
Current assets
2,265,125,000 JPY
2,755,990,000 JPY
Assets
2,290,108,000 JPY
2,757,113,000 JPY
Liabilities
Non-current liabilities
Non-current liabilities
525,571,000 JPY
520,748,000 JPY
Asset retirement obligations
JPY
2,305,000 JPY
Current liabilities
Accounts payable - other
108,785,000 JPY
36,442,000 JPY
Income taxes payable
745,000 JPY
1,490,000 JPY
Other
13,574,000 JPY
25,488,000 JPY
Asset retirement obligations
3,900,000 JPY
JPY
Advances received
28,822,000 JPY
64,751,000 JPY
Current liabilities
155,826,000 JPY
128,172,000 JPY
Liabilities
681,397,000 JPY
648,921,000 JPY
Liabilities and net assets
Shareholders' equity
1,584,173,000 JPY
2,089,944,000 JPY
Share capital
12,122,000 JPY
11,300,000 JPY
Capital surplus
2,841,101,000 JPY
2,835,204,000 JPY
Retained earnings
-1,268,943,000 JPY
-756,453,000 JPY
Treasury shares
-106,000 JPY
-106,000 JPY
Share acquisition rights
24,536,000 JPY
18,247,000 JPY
Net assets
1,608,710,000 JPY
2,108,192,000 JPY
Liabilities and net assets
2,290,108,000 JPY
2,757,113,000 JPY
Net assets
Shareholders' equity

Talk to a Data Expert

Have a question? We'll get back to you promptly.